XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
SHAREHOLDERS’ EQUITY (Tables)
6 Months Ended
Feb. 28, 2022
Equity [Abstract]  
Schedule of common stock outstanding
                    
  

Three Months Ended

February 28,

  

Six Months Ended

February 28,

 
   2022   2021   2022   2021 
Common stock outstanding, beginning of the period   20,168,796    19,958,760    20,141,521    19,923,277 
Common stock issued during the period   12,988    100,768    40,263    136,251 
Common stock outstanding, end of the period   20,181,784    20,059,528    20,181,784    20,059,528 
Schedule of dividends declared and paid
                           
(in thousands, except dividend per share)   Fiscal Year 2022              
Record Date   Distribution Date   Number of Shares
Outstanding on
Record Date
    Dividend per
Share
    Total Amount  
10/25/2021   11/01/2021     20,148     $ 0.06       1,209  
1/31/2022   2/07/2022     20,178     $ 0.06       1,211  
Total                       $ 2,420  

 

(in thousands, except dividend per share)   Fiscal Year 2021              
Record Date   Distribution Date   Number of Shares
Outstanding on
Record Date
    Dividend per
Share
    Total Amount  
10/26/2020   11/02/2020     19,924     $ 0.06     $ 1,195  
1/25/2021   2/01/2021     20,010     $ 0.06       1,201  
4/26/2021   5/03/2021     20,115     $ 0.06       1,207  
7/26/2021   8/02/2021     20,139     $ 0.06       1,208  
Total                       $ 4,811  
Schedule of stock option activity
               
(in thousands, except per share and weighted-average amounts)
Transactions during the six months ended February 28, 2022
  Number of
Options
   Weighted-
Average
Exercise
Price
Per Share
   Weighted-
Average
Remaining
Contractual
Life (Years)
 
Outstanding, August 31, 2021   1,184   $25.63    6.47 
Granted   189   $39.22      
Exercised   (44)  $17.48      
Cancelled/Forfeited   (41)  $39.72      
Outstanding, February 28, 2022   1,288   $27.45    6.47 
Exercisable, February 28, 2022   751   $16.81    4.93 
Schedule of fair value of options
          
(in thousands except pricing) 

Six Months Ended

February 28, 2022

   Fiscal Year 2021 
Estimated fair value of awards granted  $3,042   $5,092 
Unvested forfeiture rate   0%    0% 
Weighted average grant price  $39.22   $57.60 
Weighted average market price  $39.22   $57.60 
Weighted average volatility   41.91%    40.49% 
Weighted average risk-free rate   1.44%    0.64% 
Weighted average dividend yield   0.61%    0.42% 
Weighted average expected life   6.60 years    6.63 years 
Schedule of options by exercise price range
                         
(in thousands except prices)                         
Exercise Price   Awards Outstanding   Awards Exercisable 
Low   High   Quantity   Weighted
Average
Remaining
Contractual
Life
   Weighted
Average
Exercise
Price
   Quantity   Weighted
Average
Remaining
Contractual
Life
   Weighted
Average
Exercise
Price
 
$6.85   $9.77    304    3.29 years   $8.37    304    3.29 years   $8.37 
$9.78   $18.76    224    4.85 years   $10.35    223    4.84 years   $10.33 
$18.77   $33.40    268    6.91 years   $25.12    135    6.54 years   $24.16 
$33.41   $47.63    246    9.13 years   $38.35    31    7.53 years   $35.56 
$47.64   $66.14    246    8.73 years   $58.23    58    8.64 years   $58.88 
           1,288    6.47 years   $27.45    751    4.93 years   $16.81